<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate the role of <z:chebi fb="0" ids="47775">HDL-C</z:chebi> in cardiovascular risk reduction, we evaluated using data from a diabetic population in a large clinical trial with pravastatin </plain></SENT>
<SENT sid="1" pm="."><plain>A significant risk reduction in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> was found only in diabetic patients who had both a reduction in <z:chebi fb="0" ids="47774">LDL-C</z:chebi> and an increase in <z:chebi fb="0" ids="47775">HDL-C</z:chebi> </plain></SENT>
</text></document>